Startups channel feed

Re­gen­eron buys Lon­don-based oc­u­lar biotech

4 months ago
Deals
Pharma

A look at biotech's year of the megaround

4 months ago
Financing

Im­munol­o­gy biotech In­ma­gene to join Nas­daq through re­verse merg­er with what's left of Ike­na

5 months ago
Deals

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

5 months ago
Financing

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

5 months ago
Financing

David Ep­stein gets $140M for Ot­ti­mo's bi­func­tion­al take on hot PD-1xVEGF field

5 months ago
Financing

Up­dat­ed: Flag­ship gene ther­a­py start­up Ring Ther­a­peu­tics near­ly halves work­force as CEO de­parts

5 months ago
People
Cell/Gene Tx

SiteOne Ther­a­peu­tics, a pain biotech that's part­nered with Ver­tex, nabs $100M

5 months ago
Financing

Chica­go’s biotech scene is grow­ing up. What’s fu­el­ing it?

5 months ago

Ex­clu­sive: Cell ther­a­py start­up Shi­no­bi adds Borges as sci­ence chief, Katz as top med­ical of­fi­cer

5 months ago
People
Cell/Gene Tx

The Trump ad­min­is­tra­tion could breathe new life in­to the food-as-med­i­cine move­ment

5 months ago
Health Tech

Ab­b­Vie makes an­oth­er small I&I ac­qui­si­tion, buy­ing Nim­ble for $200M

5 months ago
Deals
Pharma

Eli Lil­ly has tapped tele­health start­up Ro to dis­trib­ute its sin­gle-dose Zep­bound vials

5 months ago
Pharma
Health Tech

Ex­clu­sive: Bain-backed mus­cu­loskele­tal biotech rais­es $120M for trio of clin­i­cal-stage bi­o­log­ics

5 months ago
Financing
China

Ex­clu­sive: Negev Labs un­veils with $30M in as­sets, striv­ing to build a net­work of psy­che­del­ic biotechs

5 months ago
Financing

New on­col­o­gy biotech launch­es with $52M in its pock­et

5 months ago
Financing

'It's the bi­ol­o­gy, stu­pid': Re­la­tion and GSK team up on fi­bro­sis, os­teoarthri­tis

5 months ago
Deals
AI

Bel­har­ra Ther­a­peu­tics sticks with lead pro­grams, trims work­force by 40%

5 months ago
People

Ex­clu­sive: Vi­jay Pande hands a16z biotech lead­er­ship to Vi­nee­ta Agar­wala, moves to AI role

5 months ago
People
AI

Some re­search shows pa­tients don’t stick with GLP-1s for long. Ama­zon Phar­ma­cy and Ro say they're chang­ing that

5 months ago
Pharma
Health Tech

Di­men­sion nabs $500M sec­ond fund for 'still con­trary' in­ter­sec­tion of bio and ma­chine learn­ing

5 months ago
Financing
AI

Dutch biotech nabs €85M to po­si­tion in­flam­ma­to­ry an­ti­body for a phar­ma buy­er

5 months ago
Financing

BioAge Labs scraps Phase 2 obe­si­ty tri­al just months af­ter IPO

5 months ago
R&D

GSK's third new pact of the week fo­cus­es on Alzheimer's with start­up Mu­na Ther­a­peu­tics

5 months ago
Deals
Pharma
First page Previous page 45678910 Next page Last page
A service from the Financial Times